Completed OBSERVATIONAL NCT03320980

RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma

Split-in-situ Resection With Radio-frequency Ablation Instead of Liver Partition on the First Stage (RALPPS) in Patients With Hilar and Intrahepatic Cholangiocarcinoma

Sponsor: Moscow Clinical Scientific Center

Conditions Hilar Cholangiocarcinoma Intrahepatic Cholangiocarcinoma

Interventions RALPPS portal vein embolization + major liver resection

Updated 6 times since 2017 Last updated: Oct 24, 2017 Started: Sep 15, 2014 Primary completion: Sep 20, 2017 Completion: Oct 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Hilar Cholangiocarcinoma and Intrahepatic Cholangiocarcinoma, this trial is completed. The trial is conducted by Moscow Clinical Scientific Center and has accumulated 6 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Nov 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Moscow Clinical Scientific Center

Data source: Moscow Clinical Scientific Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.